Investors Heavily Search Tenet Healthcare Corporation (THC): Here is What You Need to Know
Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Minimal Medicaid Exposure Puts Tenet Healthcare In A Good Position
Tenet Healthcare is shifting focus to ambulatory service centers, showing strong earnings growth and improved margins despite policy uncertainties and high debt levels. 2024 saw a significant one-time gain, but non-GAAP figures indicate steady operational progress, with adjusted EBITDA margins rising to 19.3%. Medicaid cuts pose less risk to Tenet due to low exposure; the company's strategic focus on ambulatory care further mitigates this concern.
Why Tenet Healthcare (THC) Outpaced the Stock Market Today
In the closing of the recent trading day, Tenet Healthcare (THC) stood at $127.75, denoting a +1.93% change from the preceding trading day.
Tenet Healthcare (THC) Sees a More Significant Dip Than Broader Market: Some Facts to Know
The latest trading day saw Tenet Healthcare (THC) settling at $119.51, representing a -1.39% change from its previous close.
Here is What to Know Beyond Why Tenet Healthcare Corporation (THC) is a Trending Stock
Tenet (THC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Here's Why Tenet Healthcare (THC) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Tenet Healthcare's Cheaper Valuation: A Hidden Gem in Healthcare?
THC is strengthening its focus on ASCs to tap into the growing demand for outpatient services.
Should Value Investors Buy Tenet Healthcare (THC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Tenet Q4 Earnings Beat Estimates on Favorable Payer Mix
THC expects net operating revenues between $20.6 billion and $21 billion in 2025.
Tenet Healthcare Corporation (THC) Q4 2024 Earnings Call Transcript
Tenet Healthcare Corporation (NYSE:THC ) Q4 2024 Earnings Conference Call February 12, 2025 10:00 AM ET Company Participants Will McDowell - Vice President of Investor Relations Saumya Sutaria - Chairman and Chief Executive Officer Sun Park - Executive Vice President and Chief Financial Officer Conference Call Participants Pito Chickering - Deutsche Bank Jamie Perse - Goldman Sachs Brian Tanquilut - Jefferies Andrew Mok - Barclays Justin Lake - Wolfe Research Benjamin Rossi - JPMorgan Chase Joanna Gajuk - Bank of America A.J Rice - UBS Stephen Baxter - Wells Fargo Michael Ha - Baird Ann Hynes - Mizuho Whit Mayo - Leerink Partners John Ransom - Raymond James Josh Raskin - Nephron Research Matthew Gillmor - KeyBanc Mike Murray - RBC Capital Markets Operator Good morning. Welcome to Tenet Healthcare's Fourth Quarter 2024 Earnings Conference Call.
Compared to Estimates, Tenet (THC) Q4 Earnings: A Look at Key Metrics
The headline numbers for Tenet (THC) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Tenet Healthcare (THC) Surpasses Q4 Earnings Estimates
Tenet Healthcare (THC) came out with quarterly earnings of $3.44 per share, beating the Zacks Consensus Estimate of $2.93 per share. This compares to earnings of $2.68 per share a year ago.
